» Articles » PMID: 24638075

Three-dimensional Lung Tumor Microenvironment Modulates Therapeutic Compound Responsiveness in Vitro--implication for Drug Development

Overview
Journal PLoS One
Date 2014 Mar 19
PMID 24638075
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Three-dimensional (3D) cell culture is gaining acceptance in response to the need for cellular models that better mimic physiologic tissues. Spheroids are one such 3D model where clusters of cells will undergo self-assembly to form viable, 3D tumor-like structures. However, to date little is known about how spheroid biology compares to that of the more traditional and widely utilized 2D monolayer cultures. Therefore, the goal of this study was to characterize the phenotypic and functional differences between lung tumor cells grown as 2D monolayer cultures, versus cells grown as 3D spheroids. Eight lung tumor cell lines, displaying varying levels of epidermal growth factor receptor (EGFR) and cMET protein expression, were used to develop a 3D spheroid cell culture model using low attachment U-bottom plates. The 3D spheroids were compared with cells grown in monolayer for 1) EGFR and cMET receptor expression, as determined by flow cytometry, 2) EGFR and cMET phosphorylation by MSD assay, and 3) cell proliferation in response to epidermal growth factor (EGF) and hepatocyte growth factor (HGF). In addition, drug responsiveness to EGFR and cMET inhibitors (Erlotinib, Crizotinib, Cetuximab [Erbitux] and Onartuzumab [MetMab]) was evaluated by measuring the extent of cell proliferation and migration. Data showed that EGFR and cMET expression is reduced at day four of untreated spheroid culture compared to monolayer. Basal phosphorylation of EGFR and cMET was higher in spheroids compared to monolayer cultures. Spheroids showed reduced EGFR and cMET phosphorylation when stimulated with ligand compared to 2D cultures. Spheroids showed an altered cell proliferation response to HGF, as well as to EGFR and cMET inhibitors, compared to monolayer cultures. Finally, spheroid cultures showed exceptional utility in a cell migration assay. Overall, the 3D spheroid culture changed the cellular response to drugs and growth factors and may more accurately mimic the natural tumor microenvironment.

Citing Articles

Cellular Systems for Colorectal Stem Cancer Cell Research.

Grigoreva T, Kindt D, Sagaidak A, Novikova D, Tribulovich V Cells. 2025; 14(3).

PMID: 39936962 PMC: 11817814. DOI: 10.3390/cells14030170.


Pharmacoproteogenomic approach identifies on-target kinase inhibitors for cancer drug repositioning.

Noguchi R, Osaki J, Ono T, Adachi Y, Iwata S, Yoshimatsu Y In Vitro Cell Dev Biol Anim. 2024; 60(10):1200-1214.

PMID: 39422823 DOI: 10.1007/s11626-024-00983-3.


Engineering vascularised organoid-on-a-chip: strategies, advances and future perspectives.

Li Z, Yu D, Zhou C, Wang F, Lu K, Liu Y Biomater Transl. 2024; 5(1):21-32.

PMID: 39220668 PMC: 11362354. DOI: 10.12336/biomatertransl.2024.01.003.


Three-Dimensional Cultivation a Valuable Tool for Modelling Canine Mammary Gland Tumour Behaviour In Vitro.

Huniadi M, Nosalova N, Almasiova V, Hornakova L, Valencakova A, Hudakova N Cells. 2024; 13(8.

PMID: 38667310 PMC: 11049302. DOI: 10.3390/cells13080695.


Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy.

Hulo P, Deshayes S, Fresquet J, Chene A, Blandin S, Boisgerault N Respir Res. 2024; 25(1):156.

PMID: 38581044 PMC: 10998296. DOI: 10.1186/s12931-024-02791-5.


References
1.
Liu T, Cohen K, Ramage J, Willingham M, Thorburn A, Frankel A . A diphtheria toxin-epidermal growth factor fusion protein is cytotoxic to human glioblastoma multiforme cells. Cancer Res. 2003; 63(8):1834-7. View

2.
Xu H, Stabile L, Gubish C, Gooding W, Grandis J, Siegfried J . Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells. Clin Cancer Res. 2011; 17(13):4425-38. PMC: 3138116. DOI: 10.1158/1078-0432.CCR-10-3339. View

3.
Yamada T, Matsumoto K, Wang W, Li Q, Nishioka Y, Sekido Y . Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer. Clin Cancer Res. 2009; 16(1):174-83. DOI: 10.1158/1078-0432.CCR-09-1204. View

4.
Yamada T, Takeuchi S, Nakade J, Kita K, Nakagawa T, Nanjo S . Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells. Clin Cancer Res. 2012; 18(13):3592-602. DOI: 10.1158/1078-0432.CCR-11-2972. View

5.
Jin H, Yang R, Zheng Z, Romero M, Ross J, Bou-Reslan H . MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival. Cancer Res. 2008; 68(11):4360-8. DOI: 10.1158/0008-5472.CAN-07-5960. View